UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition Journal article
Xia Q., Cai Y., Peng R., Wu G., Shi Y., Jiang W.. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition[J]. International Journal of Oncology, 2014, 44(3), 735.
Authors:  Xia Q.;  Cai Y.;  Peng R.;  Wu G.;  Shi Y.; et al.
Favorite | TC[WOS]:45 TC[Scopus]:49 | Submit date:2018/10/30
Brca1  Breast Cancer  Cyclin-dependent Kinase 1  Poly (Adp-ribose) Polymerase Inhibitor